Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications.
| Brand name | LIOTHYRONINE SODIUM |
| Generic name | LIOTHYRONINE SODIUM |
| Active ingredient(s) | LIOTHYRONINE SODIUM |
| Distributed by / for | Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512 |
| NDC | 62756-589-88 |
| Full product label | Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-589-88 |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide within the United States |
| Quantity | 7392 Bottles |
| Recall initiated | 2023-10-20 |
| Report date | 2023-11-08 |
| Recall completed | 2024-07-25 |
| Recall number | D-0083-2024 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗